{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:53:43Z","timestamp":1794966823890,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    More than 57 million people globally suffer from neurodegenerative diseases, a figure expected to double every 20\u2009years. Despite this growing burden, there are currently no cures, and treatment options remain limited due to disease heterogeneity, prolonged preclinical and prodromal phases, poor understanding of disease mechanisms, and diagnostic challenges. Identifying novel biomarkers is crucial for improving early detection, prognosis, staging and subtyping of these conditions. High-dimensional molecular studies in biofluids (\u2018omics\u2019) offer promise for scalable biomarker discovery, but challenges in assembling large, diverse datasets hinder progress. To address this, the Global Neurodegeneration Proteomics Consortium (GNPC)\u2014a public\u2013private partnership\u2014established one of the world\u2019s largest harmonized proteomic datasets. It includes approximately 250 million unique protein measurements from multiple platforms from more than 35,000 biofluid samples (plasma, serum and cerebrospinal fluid) contributed by 23 partners, alongside associated clinical data spanning Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). This dataset is accessible to GNPC members via the Alzheimer\u2019s Disease Data Initiative\u2019s AD Workbench, a secure cloud-based environment, and will be available to the wider research community on 15 July 2025. Here we present summary analyses of the plasma proteome revealing disease-specific differential protein abundance and transdiagnostic proteomic signatures of clinical severity. Furthermore, we describe a robust plasma proteomic signature of\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 carriership, reproducible across AD, PD, FTD and ALS, as well as distinct patterns of organ aging across these conditions. This work demonstrates the power of international collaboration, data sharing and open science to accelerate discovery in neurodegeneration research.\n                  <\/jats:p>","DOI":"10.1038\/s41591-025-03834-0","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:03:12Z","timestamp":1752591792000},"page":"2556-2566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-2568","authenticated-orcid":false,"given":"Farhad","family":"Imam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-6183","authenticated-orcid":false,"given":"Rowan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-9940","authenticated-orcid":false,"given":"Jacob W.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Krish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Abdel-Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6631","authenticated-orcid":false,"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-4625","authenticated-orcid":false,"given":"Lijun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9304-5421","authenticated-orcid":false,"given":"Federica","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Pichet Binette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-5064","authenticated-orcid":false,"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-7605","authenticated-orcid":false,"given":"Martin","family":"Bringmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-8954","authenticated-orcid":false,"given":"Jeffrey M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff L.","family":"Dage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-8883","authenticated-orcid":false,"given":"Amelia","family":"Farinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-8316","authenticated-orcid":false,"given":"Caitlin A.","family":"Finney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-7014","authenticated-orcid":false,"given":"Timothy J.","family":"Hohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-5627","authenticated-orcid":false,"given":"Mika","family":"Kivimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanna","family":"Korologou-Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2495","authenticated-orcid":false,"given":"Agustin","family":"Ruiz Laza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Liepelt-Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-7724","authenticated-orcid":false,"given":"Niklas","family":"Mattsson-Carlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-403X","authenticated-orcid":false,"given":"Lefkos T.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamilton Se-Hwee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0705-3696","authenticated-orcid":false,"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-0468","authenticated-orcid":false,"given":"Oliver","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-8532","authenticated-orcid":false,"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Shvetcov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-4847","authenticated-orcid":false,"given":"Chad","family":"Slawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Smets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-1797","authenticated-orcid":false,"given":"Betty M.","family":"Tijms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-6418","authenticated-orcid":false,"given":"Fernando","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vilor-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-9853","authenticated-orcid":false,"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-0831","authenticated-orcid":false,"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-5590","authenticated-orcid":false,"given":"Chengran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-7827","authenticated-orcid":false,"given":"Niranjan","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Global Neurodegeneration Proteomics Consortium (GNPC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"3834_CR1","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105\u2013e125 (2022)."},{"key":"3834_CR2","doi-asserted-by":"crossref","unstructured":"Huang, L., Kuan, Y., Lin, H.-W. & Hu, C. Clinical trials of new drugs for Alzheimer disease: a 2020\u20132023 update. J. Biomed. Sci. 30, 80 (2023).","DOI":"10.1186\/s12929-023-00976-6"},{"key":"3834_CR3","first-page":"CD001447","volume":"2012","author":"RG Miller","year":"2002","unstructured":"Miller, R. G., Mitchell, J. D., Lyon, M. & Moore, D. H. Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst. Rev. 2012, CD001447 (2002).","journal-title":"Cochrane Database Syst. Rev."},{"key":"3834_CR4","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer, A. L. & Sperling, R. Accelerating Alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell 186, 4757\u20134772 (2023).","journal-title":"Cell"},{"key":"3834_CR5","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement. 9, e12385 (2023)."},{"key":"3834_CR6","doi-asserted-by":"crossref","unstructured":"van der Flier, W. M., de Vugt, M. E., Smets, E. M. A., Blom, M. & Teunissen, C. E. Towards a future where Alzheimer\u2019s disease pathology is stopped before the onset of dementia. Nat. Aging 3, 494\u2013505 (2023).","DOI":"10.1038\/s43587-023-00404-2"},{"key":"3834_CR7","doi-asserted-by":"crossref","unstructured":"Blennow, K. & Zetterberg, H. Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J. Intern. Med. 284, 643\u2013663 (2018).","DOI":"10.1111\/joim.12816"},{"key":"3834_CR8","doi-asserted-by":"crossref","unstructured":"Hedl, T. J. et al. Proteomics approaches for biomarker and drug target discovery in ALS and FTD. Front. Neurosci. 13, 548 (2019).","DOI":"10.3389\/fnins.2019.00548"},{"key":"3834_CR9","doi-asserted-by":"crossref","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","DOI":"10.1002\/alz.13859"},{"key":"3834_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101735","volume":"5","author":"G Vilkaite","year":"2024","unstructured":"Vilkaite, G., Vogel, J. & Mattsson-Carlgren, N. Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer\u2019s disease. Cell Rep. Med. 5, 101735 (2024).","journal-title":"Cell Rep. Med."},{"key":"3834_CR11","doi-asserted-by":"crossref","unstructured":"Mattsson-Carlgren, N., Palmqvist, S., Blennow, K. & Hansson, O. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies. Nat. Commun. 11, 6252 (2020).","DOI":"10.1038\/s41467-020-19957-6"},{"key":"3834_CR12","doi-asserted-by":"publisher","first-page":"e70278","DOI":"10.1002\/alz.70278","volume":"21","author":"C McHugh","year":"2025","unstructured":"McHugh, C., Clement, M. & Phatak, M. AD Workbench: transforming Alzheimer\u2019s research with secure, global, and collaborative data sharing and analysis. Alzheimers Dement. 21, e70278 (2025).","journal-title":"Alzheimers Dement."},{"key":"3834_CR13","unstructured":"Alzheimer\u2019s Disease Sequencing Project (ADSP) Data Discovery Portal (National Institute on Aging Genetics of Alzheimer\u2019s Disease Data Storage Site (NIAGADS), accessed 2 July 2025); https:\/\/adsp.niagads.org\/"},{"key":"3834_CR14","unstructured":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) (ADNI, accessed 2 July 2025); https:\/\/adni.loni.usc.edu\/"},{"key":"3834_CR15","unstructured":"Accelerating Medicines Partnership\u00ae Program for Alzheimer\u2019s Disease (AMP\u00ae AD) (National Institute on Aging, US Department of Health and Human Services, National Institutes of Health, accessed 2 July 2025); https:\/\/www.nia.nih.gov\/research\/amp-ad"},{"key":"3834_CR16","unstructured":"PPMI: A Landmark Study to Identify Biomarkers of Parkinson\u2019s Disease Progression (Parkinson\u2019s Progression Markers Initiative, 2 July 2025); https:\/\/www.ppmi-info.org\/"},{"key":"3834_CR17","unstructured":"ARC Data Commons (ALS Therapy Development Institute, 2025); https:\/\/www.als.net\/arc\/data-commons\/"},{"key":"3834_CR18","unstructured":"Answer ALS: The Most Comprehensive ALS Research Initiative (Answer ALS, accessed 2 July 2025); https:\/\/www.answerals.org\/"},{"key":"3834_CR19","doi-asserted-by":"publisher","unstructured":"Ali, M. et al. Shared and disease-specific pathways in frontotemporal dementia and Alzheimer\u2019s and Parkinson\u2019s diseases. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03833-1 (2025).","DOI":"10.1038\/s41591-025-03833-1"},{"key":"3834_CR20","doi-asserted-by":"publisher","unstructured":"Farinas, A. et al. Disruption of the cerebrospinal fluid\u2013plasma protein balance in cognitive impairment and aging. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03831-3 (2025).","DOI":"10.1038\/s41591-025-03831-3"},{"key":"3834_CR21","doi-asserted-by":"publisher","unstructured":"Shvetcov, A. et al. APOE \u03b54 carriers share immune-related proteomic changes across neurodegenerative diseases. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03835-z (2025).","DOI":"10.1038\/s41591-025-03835-z"},{"key":"3834_CR22","unstructured":"AD Discovery Portal (Alzheimer\u2019s Disease Data Initiative, AD Workbench, accessed 2 July 2025); https:\/\/discover.alzheimersdata.org\/"},{"key":"3834_CR23","doi-asserted-by":"crossref","unstructured":"Toga, A. W. et al. The pursuit of approaches to federate data to accelerate Alzheimer\u2019s disease and related dementia research: GAAIN, DPUK, and ADDI. Front. Neuroinform. 17, 1175689 (2023).","DOI":"10.3389\/fninf.2023.1175689"},{"key":"3834_CR24","doi-asserted-by":"crossref","unstructured":"Oh, H. S.-H. et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat. Med. 31, 1592\u20131603 (2025).","DOI":"10.1038\/s41591-025-03565-2"},{"key":"3834_CR25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s43587-025-00872-8","volume":"5","author":"C Cruchaga","year":"2025","unstructured":"Cruchaga, C. et al. Large-scale plasma proteomic profiling unveils novel diagnostic biomarkers and pathways for Alzheimer\u2019s disease. Nat. Aging 5, 1114\u20131131 (2025).","journal-title":"Nat. Aging"},{"key":"3834_CR26","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","volume":"4","author":"EA Frick","year":"2024","unstructured":"Frick, E. A. et al. Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nat. Aging 4, 1446\u20131464 (2024).","journal-title":"Nat. Aging"},{"key":"3834_CR27","doi-asserted-by":"crossref","unstructured":"Uhlen, M. et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science 366, eaax9198 (2019).","DOI":"10.1126\/science.aax9198"},{"key":"3834_CR28","unstructured":"Sj\u00f6stedt, E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020)."},{"key":"3834_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581\u2013594 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3834_CR30","doi-asserted-by":"publisher","first-page":"e1011638","DOI":"10.1371\/journal.pgen.1011638","volume":"21","author":"EV Minikel","year":"2025","unstructured":"Minikel, E. V. & Nelson, M. R. Human genetic evidence enriched for side effects of approved drugs. PLoS Genet. 21, e1011638 (2025).","journal-title":"PLoS Genet."},{"key":"3834_CR31","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci. Transl. Med. 15, eadf0141 (2023).","journal-title":"Sci. Transl. Med."},{"key":"3834_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"H Oh","year":"2023","unstructured":"Oh, H. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"3834_CR33","doi-asserted-by":"publisher","first-page":"e14439","DOI":"10.1111\/acel.14439","volume":"24","author":"A Shvetcov","year":"2025","unstructured":"Shvetcov, A. et al. Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype. Aging Cell 24, e14439 (2025).","journal-title":"Aging Cell"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03834-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:27:42Z","timestamp":1757208462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03834-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3834"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03834-0","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L.B. receives research support from the NIH, the Tau Research Consortium, the Association for Frontotemporal Degeneration, Bluefield Project to Cure Frontotemporal Dementia, the GHR Foundation and the Alzheimer\u2019s Association. He has been a consultant for Alchemab, Alector, Alexion, Amylyx, Arrowhead, Arvinas, Eli Lilly, Muna, Neurocrine, Ono, Oscotec, Pfizer, Switch, Transposon and UnlearnAI. C.C. has received research support from GSK and Eisai. C.C. is a member of the scientific advisory board of Circular Genomics and owns stocks. C.C. is a member of the scientific advisory board of ADmit. J.L.D. has a patent pending for compounds and methods targeting human tau. L.F. has given unpaid seminars and\/or webinars sponsored or co-sponsored by SomaLogic. O.H. has received nonfinancial support from Roache and Lilly and is currently employed by Lilly. E.M.R. has received grants from National Institute on Aging and the state of Arizona; receives philanthropic funding from the Banner Alzheimer\u2019s Foundation, Sun Health Foundation and Roche\/Roche Diagnostics; receives personal fees from Alkahest, Alzheon, Aural Analytics, Denali, Green Valley, MagQ, Takeda\/Zinfandel and United Neuroscience; has since submission of manuscript become a cofounder of ALZpath, which aims to further develop P-tau217 and fluid biomarkers and advance their use in research, drug development and clinical settings; holds a patent owned by Banner Health for a strategy to use biomarkers to accelerate evaluation of Alzheimer prevention therapies; and is a principal investigator of prevention trials that include research agreements with Genentech\/Roche and Novartis\/Amgen, PET studies that include research agreements with Avid\/Lilly and several NIH and Foundation-supported research studies. T.W.-C. and H.S.-H.O. are co-founders and scientific advisors of Teal Omics Inc. and have received equity stakes. T.W.-C. is a co-founder and scientific advisor of Alkahest Inc. and Qinotto Inc. and has received equity stakes in these companies. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}